lamivudine

Generic: lamivudine oral

Labeler: chartwell govermental & specialty rx, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lamivudine
Generic Name lamivudine oral
Labeler chartwell govermental & specialty rx, llc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

lamivudine 10 mg/mL

Manufacturer
Chartwell Govermental & Specialty RX, LLC.

Identifiers & Regulatory

Product NDC 68999-706
Product ID 68999-706_476c3997-b596-17d2-e063-6394a90a6ca1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203564
Listing Expiration 2027-12-31
Marketing Start 2014-10-31

Pharmacologic Class

Established (EPC)
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68999706
Hyphenated Format 68999-706

Supplemental Identifiers

RxCUI
199148
UNII
2T8Q726O95
NUI
N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamivudine (source: ndc)
Generic Name lamivudine oral (source: ndc)
Application Number ANDA203564 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)
source: ndc

Packages (1)

68999-706-24 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)

Ingredients (1)

lamivudine (10 mg/mL)

Linked Drug Pages (1)

lamivudine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "476c3997-b596-17d2-e063-6394a90a6ca1", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199148"], "spl_set_id": ["b23aea53-324b-4ff2-8736-639e4045e388"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell Govermental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-706-24)  / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)", "package_ndc": "68999-706-24", "marketing_start_date": "20251224"}], "brand_name": "lamivudine", "product_id": "68999-706_476c3997-b596-17d2-e063-6394a90a6ca1", "dosage_form": "SOLUTION", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "68999-706", "generic_name": "lamivudine oral", "labeler_name": "Chartwell Govermental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "10 mg/mL"}], "application_number": "ANDA203564", "marketing_category": "ANDA", "marketing_start_date": "20141031", "listing_expiration_date": "20271231"}